Wenjun Chen
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
Papers in
-
- Pharmacological Effects of Natural Compounds 1
-
- Curcumin's Biomedical Applications 1
- Co-authors
- Guang-xi Zhai (1 shared paper)Feng Yuan (1 shared paper)Weidong Liu (1 shared paper)Xueyuan Heng (1 shared paper)Dezhong Sun (1 shared paper)Yingjie Zhai (1 shared paper)Miao Guo (2 shared papers)Shuli Wang (1 shared paper)
- Journals
- Pain Medicine (1 paper)World Journal of Traditional Chinese Medicine (1 paper)Lara D. Veeken (1 paper)World Journal of Surgical Oncology (1 paper)Journal of drug targeting (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenjun Chen
12 papers receiving 717 citations
Wenjun Chen's Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Medicine 284
- Biological Psychiatry 27
- Pharmaceutical Science 57
- Biomaterials 72
- Complementary and alternative medicine 37
Countries citing papers authored by Wenjun Chen
This map shows the geographic impact of Wenjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Chen more than expected).
Fields of papers citing papers by Wenjun Chen
This network shows the impact of papers produced by Wenjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Chen. The network helps show where Wenjun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oral bioavailability of curcumin: problems and advancements Hit paper breakdown → | 2016 | 478 |
| 2 | 2023 | 82 | |
| 3 | 2016 | 33 | |
| 4 | 2017 | 31 | |
| 5 | 2017 | 29 | |
| 6 | 2018 | 21 | |
| 7 | 2021 | 19 | |
| 8 | Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. | 2014 | 14 |
| 9 | 2017 | 10 | |
| 10 | 2017 | 10 | |
| 11 | Inhibition of janus kinase 2 by compound AG490 suppresses the proliferation of MDA-MB-231 cells via up-regulating SARI (suppressor of AP-1, regulated by IFN). | 2015 | 7 |
| 12 | 2024 | 2 | |
| 13 | 2024 | 0 |
About Wenjun Chen
Wenjun Chen is a scholar working on Pharmacology, Molecular Medicine, Physiology, Nephrology and Hepatology, having authored 13 papers that have together received 736 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Pain Mechanisms and Treatments (1 paper), Gout, Hyperuricemia, Uric Acid (1 paper), Voice and Speech Disorders (1 paper), Medicinal Plants and Bioactive Compounds (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Molecular Medicine (284 citations), Biological Psychiatry (27 citations), Pharmaceutical Science (57 citations), Biomaterials (72 citations) and Complementary and alternative medicine (37 citations). Wenjun Chen has collaborated with scholars based in China and United States. Frequent co-authors include Guang-xi Zhai, Feng Yuan, Weidong Liu, Xueyuan Heng, Dezhong Sun, Yingjie Zhai, Miao Guo, Shuli Wang, Xiaozhi Wu and Li Huang. Their work appears in journals such as Pain Medicine, World Journal of Traditional Chinese Medicine, Lara D. Veeken, World Journal of Surgical Oncology and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.